Continuous versus intermittent renal replacement theory in the critically ill

[1]  J. D. Smith,et al.  Fluid balance and the adult respiratory distress syndrome. , 2015, The American review of respiratory disease.

[2]  E. Klein,et al.  Microbial and endotoxin contamination in water and dialysate in the central United States. , 2008, Artificial organs.

[3]  B. Joos,et al.  Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  G. Lonnemann,et al.  Quality of water and dialysate in haemodialysis. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  E. Paganini,et al.  Refractory congestive heart failure: overview and application of extracorporeal ultrafiltration. , 1996, Advances in renal replacement therapy.

[6]  R. Jenkins.  Special Issues with Continuous Renal Replacement Therapy in Pediatric Patients , 1996 .

[7]  W. Clark,et al.  Acid‐Base Balance in Continuous Renal Replacement Therapy , 1996 .

[8]  W. Silvester,et al.  Continuous Hemofiltration in Patients with Sepsis or Multiorgan Failure , 1996 .

[9]  R. Heyka,et al.  Continuous Renal Replacement Therapy: Cost Considerations and Reimbursement , 1996 .

[10]  E. Keller.  Pharmacokinetics during Continuous Renal Replacement Therapy , 1996, The International journal of artificial organs.

[11]  Kroh Uf.  Drug administration in critically ill patients with acute renal failure. , 1995 .

[12]  E. V. Bommel.  Are continuous therapies superior to intermittent haemodialysis for acute renal failure on the intensive care unit , 1995 .

[13]  J. Chevrolet,et al.  Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. , 1994, American Journal of Kidney Diseases.

[14]  M. Zimpfer,et al.  Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration , 1994, Critical care medicine.

[15]  M. Alter,et al.  National surveillance of dialysis associated diseases in the United States, 1992. , 1994, ASAIO journal.

[16]  M. Knox,et al.  Correction of intramyocardial hypercarbic acidosis with sodium bicarbonate. , 1994, Circulatory shock.

[17]  M. Schetz.  Removal of cytokines in septic patients using continuous veno-venous hemodiafiltration. , 1994, Critical care medicine.

[18]  D. Frankenfield,et al.  Urea removal during continuous hemodiafiltration , 1994, Critical care medicine.

[19]  A. R. Morton,et al.  A comparison of continuous arteriovenous hemofiltration and intermittent hemodialysis in acute renal failure patients in the intensive care unit. , 1993, ASAIO journal.

[20]  A. Albertazzi,et al.  Efficacy and tolerance of acetate free biofiltration: a central Italian multicenter trial. , 1993, Kidney international. Supplement.

[21]  A. Davenport,et al.  Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. , 1993, Kidney international. Supplement.

[22]  J. Firth.  Renal replacement therapy on the intensive care unit. , 1993, The Quarterly journal of medicine.

[23]  P. Parsons,et al.  Mild renal ischemia activates primed neutrophils to cause acute renal failure. , 1992, Kidney international.

[24]  M. Atti,et al.  Acetate Free Biofiltration: Effects on Peripheral Blood Monocyte Activation and Cytokine Release , 1992, ASAIO journal.

[25]  K. Badr,et al.  Complement activation retards resolution of acute ischemic renal failure in the rat. , 1991, Kidney international.

[26]  J. Shapiro,et al.  Contractile dysfunction during metabolic acidosis: role of impaired energy metabolism. , 1991, The American journal of physiology.

[27]  J. Lefebvre,et al.  Kt/V: patients do not get what the physician prescribes. , 1991, ASAIO transactions.

[28]  R. Mehta,et al.  Decreased mortality in patients with acute renal failure undergoing continuous arteriovenous hemodialysis. , 1991, Contributions to Nephrology.

[29]  T. Campbell,et al.  Effects of Hyperkalemia, Acidosis, and Hypoxia on the Depression of Maximum Rate of Depolarization by Class I Antiarrhythmic Drugs in Guinea Pig Myocardium: Differential Actions of Class Ib and Ic Agents , 1991, Journal of cardiovascular pharmacology.

[30]  J. Robinette,et al.  Differences in vascular reactivity in models of ischemic acute renal failure. , 1991, Kidney international.

[31]  R. Beale,et al.  Renal support in the intensive care unit , 1991 .

[32]  R. Mehta,et al.  Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. , 1990, Kidney international.

[33]  J. Wahren,et al.  Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. , 1990, Kidney international.

[34]  J. Conger.  Does Hemodialysis Delay Recovery from Acute Renal Failure? , 1990 .

[35]  J. Turney.  Why is mortality persistently high in acute renal failure? , 1990, The Lancet.

[36]  C. Cipolla,et al.  Isolated ultrafiltration in cardiogenic pulmonary edema , 1990, Critical care medicine.

[37]  E. Klein,et al.  Endotoxin and Bacterial Contamination of Dialysis Center Water and Dialysate; a Cross Sectional Survey , 1990, The International journal of artificial organs.

[38]  K. Nolph,et al.  The Peak Concentration Hypothesis: A Urea Kinetic Approach to Comparing the Adequacy of Continuous Ambulatory Peritoneal Dialysis (CAPD) and Hemodialysis , 1989 .

[39]  J. Moorhead,et al.  Prognosis of critically-ill patients with acute renal failure: APACHE II score and other predictive factors. , 1989, The Quarterly journal of medicine.

[40]  B. Wikström,et al.  Continuous arteriovenous hemofiltration in the treatment of 100 critically ill patients with acute renal failure: report on clinical outcome and nutritional aspects. , 1989, Clinical nephrology.

[41]  G. Hill,et al.  Grip strength: A measure of the proportion of protein loss in surgical patients , 1988, The British journal of surgery.

[42]  G. Hill,et al.  Risk Factors for Postoperative Pneumonia: The Importance of Protein Depletion , 1988, Annals of surgery.

[43]  M. Avram,et al.  Hemodynamic consequences of continuous arteriovenous hemofiltration. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  E. Brown,et al.  CONTINUOUS ARTERIOVENOUS HAEMODIALYSIS IN CRITICALLY ILL PATIENTS , 1988, The Lancet.

[45]  A. Kaplan,et al.  Regional heparinization for continuous arterio-venous hemofiltration (CAVH). , 1987, ASAIO transactions.

[46]  J. Robinette,et al.  Effect of hemorrhagic reduction in blood pressure on recovery from acute renal failure. , 1987, Kidney international.

[47]  C. Dinarello,et al.  ENHANCEMENT OF IN-VITRO HUMAN INTERLEUKIN-1 PRODUCTION BY SODIUM ACETATE , 1987, The Lancet.

[48]  R. Dechert,et al.  Continuous arteriovenous hemofiltration: improved survival in surgical acute renal failure? , 1986, Surgery.

[49]  W. Mauritz,et al.  [Acute renal failure in abdominal infection. Comparison of hemodialysis and continuous arteriovenous hemofiltration]. , 1986, Anasthesie, Intensivtherapie, Notfallmedizin.

[50]  C. Ronco,et al.  Treatment of acute renal failure in newborns by continuous arterio-venous hemofiltration. , 1986, Kidney international.

[51]  T. Golper.  Continuous arteriovenous hemofiltration in acute renal failure. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[52]  N. Kay,et al.  Leukocyte abnormalities in renal failure and hemodialysis. , 1985, Seminars in nephrology.

[53]  G. Pozza,et al.  Artificial Devices for Continuous Insulin Administration: An Outlook , 1984, The International journal of artificial organs.

[54]  H. Harter.  Review of significant findings from the National Cooperative Dialysis Study and recommendations. , 1983, Kidney international. Supplement.

[55]  P. Keshaviah,et al.  A critical examination of dialysis-induced hypotension. , 1982, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[56]  J. V. van Stone,et al.  The effect of dialysate sodium concentration on body fluid compartment volume, plasma renin activity and plasma aldosterone concentration in chronic hemodialysis patients. , 1982, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[57]  N. Laird,et al.  Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. , 1981, The New England journal of medicine.

[58]  D. Matthaei,et al.  Management of anuric intensive-care patients with arteriovenous hemofiltration , 1980, The International journal of artificial organs.

[59]  E. Demaster,et al.  Hemodialysis induced hypotension. , 1978, The International journal of artificial organs.

[60]  R. Maiorca,et al.  Blood pressure behaviour during dialysis and ultrafiltration. A pathogenic hypothesis on hemodialysis-induced hypotension. , 1978, The International journal of artificial organs.

[61]  M. Weinstein,et al.  Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.

[62]  E. Reynolds,et al.  ONE DRUG (PHENYTOIN) IN TREATMENT OF EPILEPSY , 1976, The Lancet.

[63]  L. Smith,et al.  Post-traumatic renal insufficiency in military casualties. I. Clinical characteristics. , 1955, The American journal of medicine.

[64]  L. Smith,et al.  Post-traumatic renal insufficiency in military casualties. II. Management, use of an artificial kidney, prognosis. , 1955, The American journal of medicine.

[65]  M. N. Marra,et al.  Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[66]  R. Bellomo,et al.  Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. , 1995, Renal failure.

[67]  H. Bruining,et al.  Acute dialytic support for the critically ill: intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. , 1995, American journal of nephrology.

[68]  R. Bellomo,et al.  Severe acute renal failure: a comparison of acute continuous hemodiafiltration and conventional dialytic therapy. , 1995, Nephron.

[69]  R. Bellomo,et al.  Acute Renal Failure in the Critically Ill , 1995, Update in Intensive Care and Emergency Medicine.

[70]  C. Leue,et al.  Continuous venovenous hemofiltration in acute renal failure: is a bicarbonate- or lactate-buffered substitution better? , 1995, Contributions to nephrology.

[71]  R. Bellomo,et al.  Treatment of sepsis-associated severe acute renal failure with continuous hemodiafiltration: clinical experience and comparison with conventional dialysis. , 1995, Blood purification.

[72]  D. Journois.  Complement fragments and cytokines: production and removal as consequences of hemofiltration. , 1995, Contributions to nephrology.

[73]  R. Bellomo,et al.  Acute Renal Failure in the Intensive Care Unit: Which Treatment Is Best? , 1995 .

[74]  W. Clark,et al.  A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. , 1994, Journal of the American Society of Nephrology : JASN.

[75]  P. Fauchald,et al.  Hormonal changes in patients with severe chronic congestive heart failure treated by ultrafiltration. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[76]  W. Hörl,et al.  Effect of malnutrition and uremia on impaired cellular host defence. , 1992, Mineral and electrolyte metabolism.

[77]  A. Davenport,et al.  The prognostic use of a lactate infusion in patients with severe hepatorenal failure. , 1991, Renal failure.

[78]  K. Klouche,et al.  Acute renal failure associated with multiple organ failure: pump-assisted continuous venovenous hemofiltration, the ultimate treatment modality. , 1991, Contributions to nephrology.

[79]  H. Kierdorf.  Continuous versus intermittent treatment: clinical results in acute renal failure. , 1991, Contributions to nephrology.

[80]  P. Pouard,et al.  Assessment of standardized ultrafiltrate production rate using prostacyclin in continuous venovenous hemofiltration. , 1991, Contributions to nephrology.

[81]  K. Klouche,et al.  Slow continuous ultrafiltration: a means of unmasking myocardial functional reserve in end-stage cardiac disease. , 1991, Contributions to nephrology.

[82]  J. Turney,et al.  The evolution of acute renal failure, 1956-1988. , 1990, The Quarterly journal of medicine.

[83]  F. Keller,et al.  Risk factors of system clotting in heparin-free haemodialysis. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[84]  V. Armstrong,et al.  Low molecular weight heparin versus standard heparin. A long-term study in hemodialysis and hemofiltration patients. , 1990, ASAIO transactions.

[85]  D. Heney,et al.  Continuous arteriovenous haemofiltration in the newlyborn with acute renal failure and congenital heart disease. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[86]  Kjellstrand Cm,et al.  Continuous arteriovenous hemofiltration: a comparison with hemodialysis in acute renal failure. , 1985 .

[87]  S. Nakamoto,et al.  Slow continuous ultrafiltration in hemodialysis resistant oliguric acute renal failure patients. , 1984, Transactions - American Society for Artificial Internal Organs.

[88]  R. Geronemus,et al.  Continuous arteriovenous hemodialysis: a new modality for treatment of acute renal failure. , 1984, Transactions - American Society for Artificial Internal Organs.

[89]  A. Nissenson,et al.  Dialysis-associated hypoxemia: pathogenesis and prevention , 1984 .

[90]  R. Dechert,et al.  Starvation: a major contribution to mortality in acute renal failure? , 1983, Transactions - American Society for Artificial Internal Organs.

[91]  F. Valderrábano,et al.  Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena. , 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

[92]  C. Ronco,et al.  Studies on brain density in hemodialysis and peritoneal dialysis. , 1982, Nephron.

[93]  C. Ronco,et al.  Study on morphological and densitometrical changes in the brain after hemodialysis and peritoneal dialysis. , 1981, Transactions - American Society for Artificial Internal Organs.

[94]  G WhittakerP,et al.  共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値 , 1980 .

[95]  E. Constantini,et al.  The influence of ultrafiltration (UF) and diffusion (D) on cardiovascular parameters. , 1980, Transactions - American Society for Artificial Internal Organs.

[96]  Bower Jd,et al.  A comparison of the cardiovascular effects of sodium acetate, sodium bicarbonate and other potential sources of fixed base in hemodialysate solutions. , 1977 .

[97]  K. Koch,et al.  Plasma noradrenaline levels in regular haemodialysis patients. , 1976, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.